ScholarSpace will be down for maintenance on Thursday (8/16) at 8am HST (6pm UTC)
Please use this identifier to cite or link to this item:

Methylglyoxal-Modification of Human Serum Albumin Alters Bilirubin Binding

File Description SizeFormat 
2015-12-ms-to_r.pdfVersion for non-UH users. Copying/Printing is not permitted2.95 MBAdobe PDFView/Open
2015-12-ms-to_uh.pdfFor UH users only3.05 MBAdobe PDFView/Open

Item Summary

Title: Methylglyoxal-Modification of Human Serum Albumin Alters Bilirubin Binding
Authors: To, Albert
Keywords: Human serum albumin
show 4 morestructure
drug binding site I
drug binding site II

show less
Issue Date: Dec 2015
Publisher: [Honolulu] : [University of Hawaii at Manoa], [December 2015]
Abstract: The glycation of protein is a non-enzymatic post-translational modification targeting terminal amines of positively-charged amino acids, and has been linked to the progression of diabetic complications. Methylglyoxal (MG) is a potent glycating agent elevated in individuals with prolonged hyperglycemia and in the elderly, with the ability to change both the structure and function of protein. Due to its abundance and high molar-ratio of lysine and arginine, human serum albumin (HSA) is highly susceptible to the effects of pathological glycaemia. Glycation of HSA by MG has resulted in decreased affinity for several drugs and cellular metabolites, possibly due to the glycation of amino acids responsible for electrostatic interaction and hydrogen bonding within the ligand binding site. Among the molecules affected is bilirubin, a tetrapyrrolic metabolic of heme, which binds to circulating HSA in a binding pocket housing the potential glycation site R218.
Recombinant R218 variants, wtHSA, R218M, R218H, R218A, and R218E, were synthesized to mimic the effects of glycation at this site, and used to study the how bilirubin binding is altered. Our results suggest positively-charged and sterically hindering residues at position 218 discourage association. R218 unfavorably influence the binding of bilirubin, but its presence is required in the event of glycation for proper function. Unglycated R218M and R218E had a Kd two-folds greater than wtHSA while R218A had a 10-fold increase. Glycation severely depressed affinity of bilirubin in all non-wtHSA. This suggests multiple site modification per mole of HSA, and conformational changes resulting from allosterism is responsible the decreased functionality. Although the absence of R218 is clearly implicated in the function of glycated albumin, further studies will be needed to determine the exact mechanism of functional impairment.
Description: M.S. University of Hawaii at Manoa 2015.
Includes bibliographical references.
Appears in Collections:M.S. - Molecular Biosciences and Bioengineering

Please email if you need this content in an ADA-compliant format.

Items in ScholarSpace are protected by copyright, with all rights reserved, unless otherwise indicated.